$ACRS SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more (Address of principal executive offices, including zip code)
21 Sep 2026	SCHEDULE 13G
14 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	8-K: Entry into a Material Definitive Agreement
06 Aug 2026	S-3ASR
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	Form 4: Kolbeck Roland Wilhelm, Chief Scientific Officer Received 36,375 shares by exercise or conversion · Gave up 12,385 shares to cover exercise price or tax ($64.4K)
08 Jun 2026	Form 4: Mehra Anand, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Schiff Andrew N, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Humphries William D., Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Molineaux Christopher P., Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Milano Vincent, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Gowen Maxine, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 May 2026	SCHEDULE 13G/A
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
05 May 2026	Form 4: Hall Jesse Wayne, Chief Medical Officer Received 36,375 shares by exercise or conversion · Gave up 9,330 shares to cover exercise price or tax ($41.1K)
28 Apr 2026	8-K: Regulation FD Disclosure; Other Events

Comments